Thalia Therapeutics Plc (AIM:THAT)

Thalia Therapeutics Balance Sheet

Financials in millions GBP. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	1.08	0.63	1.03	1.92	1.78
Cash & Short-Term Investments	1.08	0.63	1.03	1.92	1.78
Cash Growth	72.42%	-39.05%	-46.49%	7.60%	-49.83%
Other Receivables	0.07	0.13	0.18	0.21	0.55
Receivables	0.07	0.13	0.18	0.21	0.55
Prepaid Expenses	0.02	0.02	0.01	0.04	0.01
Total Current Assets	1.17	0.78	1.21	2.17	2.34
Goodwill	-	-	0.06	-	-
Total Assets	1.17	0.78	1.28	2.17	2.34
Accounts Payable	0.03	0.02	0.02	0.04	0.18
Accrued Expenses	0.07	0.1	0.06	0.04	0.03
Other Current Liabilities	0	0.01	0.01	0	0
Total Current Liabilities	0.1	0.12	0.08	0.08	0.21
Total Liabilities	0.1	0.12	0.08	0.08	0.21
Common Stock	3.33	1.58	1.08	0.94	0.72
Additional Paid-In Capital	14.69	14.94	14.87	14.7	13.95
Retained Earnings	-11.56	-10.4	-9.34	-8.06	-7.03
Comprehensive Income & Other	-5.39	-5.47	-5.48	-5.48	-5.51
Total Common Equity	1.07	0.65	1.13	2.09	2.13
Minority Interest	0	0	0.07	-	-
Shareholders' Equity	1.07	0.65	1.19	2.09	2.13
Total Liabilities & Equity	1.17	0.78	1.28	2.17	2.34
Net Cash (Debt)	1.08	0.63	1.03	1.92	1.78
Net Cash Growth	72.42%	-39.05%	-46.49%	7.60%	-49.83%
Net Cash Per Share	0.00	0.00	0.00	0.01	0.01
Filing Date Shares Outstanding	832.28	394.78	268.78	233.78	181.08
Total Common Shares Outstanding	832.28	394.78	268.78	233.78	181.08
Working Capital	1.07	0.65	1.13	2.09	2.13
Book Value Per Share	0.00	0.00	0.00	0.01	0.01
Tangible Book Value	1.07	0.65	1.07	2.09	2.13
Tangible Book Value Per Share	0.00	0.00	0.00	0.01	0.01

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Jul 3, 2026

Data Sources Report a data error